2-Hydroxy-N-[2-[3-Methyl-2-Oxo-7-[[3-(Trifluoromethyl)Phenyl]Methylamino]Quinoxalin-1-Yl]Ethyl]Acetamide

CVT-12012 has several potential applications:

• Cancer Therapy: As an inhibitor of stearoyl-CoA desaturase 1, it may be used in developing anticancer therapies aimed at metabolic reprogramming.
• Metabolic Disorders: Its ability to modulate lipid profiles suggests potential use in treating conditions like obesity and type 2 diabetes.
• Research Tool: It serves as a valuable tool for studying lipid metabolism and the role of fatty acids in cellular processes.

CVT-12012 exhibits significant biological activity related to cancer treatment. The inhibition of stearoyl-CoA desaturase 1 has been linked to reduced proliferation and increased apoptosis in cancer cells. Studies indicate that targeting this enzyme can disrupt the metabolic adaptations that cancer cells utilize for growth and survival. Additionally, CVT-12012's effects on lipid metabolism may enhance insulin sensitivity and contribute to weight management.

Please email your required order quantity and detailed technical specifications to sales@.
Our sales team will promptly prepare an accurate quotation for your bulk order and provide a comprehensive pricing proposal.

All products are for research and development use only, not for any other uses, and must be handled by technically-qualified persons.

These products are explicitly not intended to be used in foods and/or cosmetics and/or drugs (human and veterinary) and/or consumer products and/or biocides and/or pesticides of any kind unless explicitly stated otherwise.

Products are not sold to individuals. We do not ship to residential addresses. Consumer orders will be cancelled without notice.

New customers undergo an internal onboarding process. As part of this process, new customers may be asked for more information. Additional restrictions may apply.